New data from CIMZIA WELCOME trial to be presented at the ACG meeting

28. October 2009 08:22

According to new results from the WELCOME trial, exploratory data analyzing the impact of treatment with CIMZIA(®) (certolizumab pegol) - the only PEGylated anti-TNF (alpha) (Tumor Necrosis Factor alpha) - administered either every two weeks or every four weeks, showed that the majority of Crohn's disease patients in both dosing groups experienced no hospitalizations and surgical procedures during the course of the 26-week study. [More]

dc4421a5-6474-4f57-8556-7aab68f3c0ca|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Abatacept, Anemia, Angioedema, Antibody, Arthralgia, Arthritis, Autoimmune Disease, Cancer, Congestive Heart Failure, Crohn's Disease, Dyspnea, Exercise, Gastroenterology, Headache, Heart Failure, Hepatitis B, Hospital, Hypersensitivity, Immunology, Inflammatory Bowel Disease, Infliximab, Leukopenia, Listeriosis, Lupus, Lymphoma, Melanoma, Methotrexate, Nausea, Nervous System, Neuropathy, Rheumatoid Arthritis, Rituximab, Sepsis, Skin Cancer, Thrombocytopenia, TNF Blockers, Tuberculosis, Ulcerative Colitis, Urticaria, Virus, Vomiting

New data from efficacy study of CIMZIA in Crohn's disease patients presented

27. October 2009 05:04

New data from an open-label extension study evaluating the long-term safety and efficacy of CIMZIA® (certolizumab pegol) in moderate to severe Crohn's disease patients demonstrate that 82 percent of patients actively treated with CIMZIA - the only PEGylated anti-TNF-alpha (Tumor Necrosis Factor alpha) - remained in long-term remission without dose escalation up to 3.5 years. [More]

f9ebb83c-178d-48e4-93ba-4733f68dec6a|0|.0

Posted in: Drug Trial News | Disease/Infection News

Tags: Abatacept, Abdominal Pain, Anemia, Angioedema, Antibody, Arthritis, Autoimmune Disease, Cancer, Congestive Heart Failure, Cough, Crohn's Disease, Dyspnea, Exercise, Gastroenterology, Headache, Heart Failure, Hepatitis B, Hypersensitivity, Immunology, Inflammatory Bowel Disease, Leukopenia, Listeriosis, Lupus, Lymphoma, Melanoma, Methotrexate, Nervous System, Neuropathy, Pneumonia, Rheumatoid Arthritis, Rituximab, Sepsis, Skin Cancer, Thrombocytopenia, TNF Blockers, Tuberculosis, Ulcerative Colitis, Urticaria, Virus

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

21. October 2009 06:30

Bristol-Myers Squibb Company announced today that new clinical data support continued development of a subcutaneous administration of ORENCIA® (abatacept) for patients with moderate to severe rheumatoid arthritis. [More]

8daed20b-21db-46ba-b6e2-cf27ce0097c6|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Abatacept, Adenine, Antibody, Arthritis, Cancer, Cough, Dyspnea, Education, Headache, Hypersensitivity, Immunization, Lung Cancer, Lymphoma, Methotrexate, Nausea, Nicotine, Nursing, Pneumonia, Pregnancy, Rheumatoid Arthritis, Rheumatology, Tuberculosis, Urticaria

Bristol-Myers Squibb presents study data on ORENCIA for treating rheumatoid arthritis

20. October 2009 05:37

Bristol-Myers Squibb Company today announced two-year results of a study that supports use of ORENCIA® (abatacept) for methotrexate-naive patients with moderate to severe rheumatoid arthritis of less than or equal to two years duration. [More]

6b028613-1553-4058-837b-a0a617d4a5ea|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Abatacept, Adenine, Arthritis, Cancer, Cough, Dyspnea, Education, Headache, Hypersensitivity, Immunization, Lung Cancer, Lymphoma, Methotrexate, Nausea, Nicotine, Nursing, Pneumonia, Pregnancy, Rheumatoid Arthritis, Rheumatology, Tuberculosis, Urticaria

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

20. October 2009 05:35

Phase 3 data reported for the first time show that once every four week subcutaneous injections of SIMPONI(TM) (golimumab) resulted in significantly greater inhibition of structural damage compared with placebo plus methotrexate in patients with active rheumatoid arthritis (RA) and active psoriatic arthritis (PsA). [More]

fecd05bb-f5de-4327-bddc-9855b00e1fef|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Abatacept, Allergy, Ankylosing Spondylitis, Antibody, Arthritis, Basal Cell Carcinoma, Blood Pressure, Bone, Breast Cancer, Bronchitis, Cancer, Cartilage, Cell, Cold Sores, Cough, Diabetes, Diarrhea, Education, Golimumab, Heart Failure, Hepatitis B, Hodgkin's Disease, Immunology, Inflammatory Disease, Lung Cancer, Lupus, Lymphoma, Methotrexate, Monoclonal Antibody, Multiple Sclerosis, Nausea, Nephrology, Nervous System, Oncology, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Rheumatology, Rituximab, Sepsis, Skin Cancer, Squamous Cell Carcinoma, TNF Blockers, Tuberculosis, Vaccine, Virus, Vomiting, Weight Loss

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

19. October 2009 23:55

UCB today announced data that showed rapid and sustained improvements in ACR20, physical function, pain and fatigue of rheumatoid arthritis (RA) as early as the first week, and inhibition of progression of structural joint damage (seen at week 24) following treatment with Cimzia (certolizumab pegol), together with methotrexate (MTX), was sustained up to 100 weeks. [More]

9fa30521-bee5-4c51-87b2-372a20331b94|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Abatacept, Anemia, Angioedema, Antibody, Anti-Inflammatory, Arthralgia, Arthritis, Autoimmune Disease, Back Pain, Bone, Bronchitis, Cancer, Congestive Heart Failure, Crohn's Disease, Dyspnea, Exercise, Headache, Heart Failure, Hepatitis B, Hospital, Hypersensitivity, Immunology, Leukopenia, Listeriosis, Lupus, Lymphoma, Melanoma, Methotrexate, Nervous System, Neuropathy, Rheumatoid Arthritis, Rheumatology, Rituximab, Sepsis, Skin Cancer, Thrombocytopenia, TNF Blockers, Tuberculosis, Urinary Tract Infection, Urticaria, Virus

More studies needed to compare the efficacy of different biologic drugs for RA, say researchers

7. October 2009 04:34

More studies that directly compare the effectiveness of different biologic drugs for rheumatoid arthritis (RA) are needed, say Cochrane Researchers. The researchers reviewed all previous Cochrane Systematic Reviews assessing the effectiveness of biologic disease-modifying drugs for treatment of RA and found that although all were very effective, there was little data on direct comparisons between the drugs that could help doctors decide which to prescribe. [More]

17550acc-8d66-47bd-94f2-3bde9f5e4c7d|0|.0

Posted in: Medical Condition News

Tags: Abatacept, Adalimumab, Arthritis, Autoimmune Disease, Etanercept, Infliximab, Methotrexate, Rheumatoid Arthritis, Rituximab, Veterans Affairs

Cochrane Systematic Review finds Abatacept effective against rheumatoid arthritis

7. October 2009 03:09

Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis (RA), is effective against RA, according to a new Cochrane Systematic Review. The review examines recent trials to assess safety and efficacy of the drug. [More]

85bdfd26-0abc-464a-85f2-1606d8e4c987|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Abatacept, Arthritis, Autoimmune Disease, Rheumatoid Arthritis

Cimzia approved for treating adult patients with rheumatoid arthritis

1. September 2009 06:41

UCB Canada Inc. announced today that Health Canada has approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). [More]

c1be306d-a0a9-4d00-9b96-0ac6eca3c5e4|0|.0

Posted in: Drug Trial News | Pharmaceutical News

Tags: Abatacept, Anemia, Angioedema, Arthritis, Basal Cell Carcinoma, Cell, Congestive Heart Failure, Dyspnea, Exercise, Heart Failure, Hepatitis B, Herpes, Hospital, Hypersensitivity, Immunology, Leukopenia, Listeriosis, Lupus, Lymphoma, Melanoma, Methotrexate, Nervous System, Neuropathy, Prophylaxis, Rheumatoid Arthritis, Sepsis, Thrombocytopenia, TNF Blockers, Tuberculosis, Urticaria, Virus

Clinical data added to ORENCIA labeling help treat patients with rheumatoid arthritis

27. August 2009 06:56

Bristol-Myers Squibb Company announced today that clinical data added to the labeling for ORENCIA (abatacept) support use of ORENCIA for patients with moderate to severe rheumatoid arthritis of less than or equal to two years duration. [More]

5fd4e72e-9cb1-4a1e-b60e-a593b67a6d91|0|.0

Posted in: Pharmaceutical News

Tags: Abatacept, Adenine, Arthritis, Cancer, Cough, Dyspnea, Education, Headache, Hypersensitivity, Immunization, Lung Cancer, Lymphoma, Methotrexate, Nausea, Nicotine, Nursing, Pneumonia, Pregnancy, Rheumatoid Arthritis, Rheumatology, Tuberculosis, Urticaria

Arthritis drug Abatacept may be effective in fighting the flu

26. May 2009 16:39

Researchers at the University of Maryland School of Medicine have found that an approved drug for treating rheumatoid arthritis reduces severe illness and death in mice exposed to the Influenza A virus. Their findings suggest that tempering the response of the body's immune system to influenza infection may alleviate some of the more severe symptoms and even reduce mortality from this virus. [More]

c7173d39-cb94-44fc-994a-8ff9ce4501d3|1|3.0

Posted in: Medical Research News

Tags: Abatacept, H1N1, Immunology, Influenza, Rheumatoid Arthritis, Swine Flu, Tamiflu (Oseltamivir), Virus

Cimzia approved in U.S. for rheumatoid arthritis

13. May 2009 23:11

UCB announced today that the U.S. Food and Drug Administration (FDA) approved Cimzia, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). [More]

3888905d-1599-4bf4-a85e-aa48bed64502|2|3.0

Posted in: Pharmaceutical News

Tags: Abatacept, Anemia, Angioedema, Antibody, Antimicrobial Drug, Arthralgia, Arthritis, Autoimmune Disease, Bronchitis, Cimzia (Certolizumab pegol), Congestive Heart Failure, Corticosteroid, Crohn's Disease, Dyspnea, Heart Failure, Hepatitis B, Hypertension (High Blood Pressure), Leukopenia, Listeriosis, Lupus, Lymphoma, Methotrexate, Neuropathy, Peripheral Neuropathy, Rheumatoid Arthritis, Rituximab, TNF Blockers, Urinary Tract Infection, Virotherapy, Virus

Watery pools in bone marrow key to psoriatic arthritic damage

4. March 2008 18:34

Researchers have learned more about how a leading drug prevents certain types of arthritis from eating away at bone, according to a study published in the March edition of the Annals of the Rheumatic Diseases. [More]

b0746615-6d5e-4a8b-9142-f2d3ad93b088|0|.0

Posted in: Drug Trial News

Tags: Abatacept, Arthritis, Autoimmune Disease, Biomarker, Bone, Bone Marrow, Edema, Embryology, Etanercept, Macrophage, Non-Steroidal Anti-Inflammatory Drug (NSAIDS), Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Rituximab, Stem Cell, TNF Blockers

Combining medications often best strategy to battle rheumatoid arthritis

18. December 2007 02:31

For patients with rheumatoid arthritis, combining one well-known, lower cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report funded by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services. [More]

c6d68875-f8cf-4c10-a719-e99c27308c7f|0|.0

Posted in: Drug Trial News

Tags: Abatacept, Adalimumab, Anemia, Arthritis, Autoimmune Disease, Biologics Drug / Agent, Corticosteroid, Etanercept, Infliximab, Methotrexate, Physical Therapy, Rheumatoid Arthritis, Rituximab, Tuberculosis

Combining medications often best strategy to battle rheumatoid arthritis

19. November 2007 22:05

For patients with rheumatoid arthritis, combining one well-known, lower-cost synthetic drug with one of six biologic medications often works best to reduce joint swelling or tenderness, according to a new report by researchers at the RTI International-University of North Carolina at Chapel Hill Evidence-based Practice Center, which is sponsored by the Agency for Healthcare Research and Quality. [More]

9ea8a692-d02e-4374-a883-c764623eed47|0|.0

Posted in: Drug Trial News

Tags: Abatacept, Adalimumab, Anemia, Arthritis, Autoimmune Disease, Biologics Drug / Agent, Corticosteroid, Etanercept, Infliximab, Methotrexate, Physical Therapy, Psoriatic Arthritis, Rheumatoid Arthritis, Rituximab, Tuberculosis

Free!

Recent Comments

Twitter

Information

Abatacept News and Research

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

New data from efficacy study of CIMZIA in Crohn's disease patients presented

Clinical data supports continued development of ORENCIA administration for rheumatoid arthritis

Bristol-Myers Squibb presents study data on ORENCIA for treating rheumatoid arthritis

SIMPONI treatment results in greater inhibition of structural damage in arthritis patients

UCB reports on the outcome of Cimzia and MTX treatment for rheumatoid arthritis

More studies needed to compare the efficacy of different biologic drugs for RA, say researchers

Cochrane Systematic Review finds Abatacept effective against rheumatoid arthritis

Cimzia approved for treating adult patients with rheumatoid arthritis

Clinical data added to ORENCIA labeling help treat patients with rheumatoid arthritis

Arthritis drug Abatacept may be effective in fighting the flu

Cimzia approved in U.S. for rheumatoid arthritis

Watery pools in bone marrow key to psoriatic arthritic damage

Combining medications often best strategy to battle rheumatoid arthritis

Combining medications often best strategy to battle rheumatoid arthritis

Recent Articles

Free!

Recent Comments

Twitter

Information

Abatacept News and Research

Medical News Cloud

Recent Articles